Kategorien
Aktien

Halozyme Therapeutics Inc 35,51 EUR +0,42% 

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
ISIN US40637H1095
USD
↓
  • Halozyme Therapeutics Inc
    Börse Börse Frankfurt
    Symbol RV7
    EUR
  • HALOZYME THERAPEUTICS INC
    Börse Börse Düsseldorf
    Symbol RV7
    EUR
  • HALOZYME THERAPEUTICS INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol RV7
    EUR
  • HALOZYME THERAPEUTICS INC
    Börse Quotrix System der Börse Düsseldorf
    Symbol RV7
    EUR
  • HALOZYME THERAPEUTICS INC
    Börse Gettex System der Börse München
    Symbol RV7
    EUR
  • HALOZYME THERAPEUTICS INC
    Börse Börse Stuttgart
    Symbol RV7
    EUR
  • ISIN US40637H1095 WKN: A0DLHS
    Symbol HALO
    USD
  • Symbol RV7
    EUR
  • Symbol RV7
    EUR
  • USD
ISIN US40637H1095
WKN A0DLHS
Symbol HALO
Währung USD
Mitarbeiter 393

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 35,51 EUR +0,42% 

23 News & Informationen zur Halozyme Therapeutics Inc Aktie

  • Halozyme Therapeutics Inc (HALO): Price Now Near $41.71; Daily Chart Shows Downtrend on 50 Day Basis
    etfdailynews.com

    Halozyme Therapeutics Inc (HALO): Price Now Near $41.71; Daily Chart Shows Downtrend on 50 Day Basis

    Of note is that the 50 day changed directions on halo; it is now pointing down.

  • Global Antidiabetic Drug Market Report 2021-2026 - Opportunities in New Innovations
    prnewswire.com

    Global Antidiabetic Drug Market Report 2021-2026 – Opportunities in New Innovations

    /PRNewswire/ — The “Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of…

  • Halozyme Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:HALO)
    seekingalpha.com

    Halozyme Therapeutics, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:HALO)

    The following slide deck was published by Halozyme Therapeutics, Inc.

  • Halozyme Therapeutics Inc (HALO) President and CEO Helen Torley Sold $2.1 million of Shares
    gurufocus.com

    Halozyme Therapeutics Inc (HALO) President and CEO Helen Torley Sold $2.1 million of Shares

    GuruFocus Article or News written by insider and the topic is about:

  • Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q2 2021 Results – Earnings Call Transcript

    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q2 2021 Earnings Conference Call August 09, 2021, 04:30 PM ET Company Participants Al Kildani – Vice President of Investor Relations and Corporate…

  • Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates
    zacks.com

    Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates

    Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 53.49% and 30.79%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Earnings Scheduled For August 9, 2021
    benzinga.com

    Earnings Scheduled For August 9, 2021

    Companies Reporting Before The Bell
    • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of …

  • Halozyme Therapeutics Q2 2021 Earnings Preview (NASDAQ:HALO)
    seekingalpha.com

    Halozyme Therapeutics Q2 2021 Earnings Preview (NASDAQ:HALO)

    Halozyme Therapeutics (NASDAQ:HALO) is scheduled to announce Q2 earnings results on Monday, August 9th, after market close.The consensus EPS Estimate is $0.44 (+131.6% Y/Y) and…

  • The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    markets.businessinsider.com

    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…

  • Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference
    prnewswire.com

    Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference

    /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun, senior vice president and chief financial officer, will virtually…

  • Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio...
    thestreet.com

    Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion

    DUBLIN, July 29, 2021 /PRNewswire/ — The

  • Brixmor Property Group Inc (BRX): Are Hedge Funds Right About This Stock?
    insidermonkey.com

    Brixmor Property Group Inc (BRX): Are Hedge Funds Right About This Stock?

    In this article we are going to use hedge fund sentiment as a tool and determine whether Brixmor Property Group Inc (NYSE:BRX) is a good investment right…

  • SkyOak Wealt, LLC Buys Industrial Select Sector SPDR, Materials Select Sector SPDR, PIMCO Enhanced Low Duration Active Exchange-Traded,...
    gurufocus.com

    SkyOak Wealt, LLC Buys Industrial Select Sector SPDR, Materials Select Sector SPDR, PIMCO Enhanced Low Duration Active Exchange-Traded, Sells Communication Services Select Sector SPDR Fund, Consumer D

    GuruFocus Article or News written by insider and the topic is about:

  • Lateef Investment Management, L.p. Buys Lithia Motors Inc, AerCap Holdings NV, Ball Corp, Sells Lululemon Athletica Inc, Danaher Corp,...
    gurufocus.com

    Lateef Investment Management, L.p. Buys Lithia Motors Inc, AerCap Holdings NV, Ball Corp, Sells Lululemon Athletica Inc, Danaher Corp, IQVIA Holdings Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Where Do Hedge Funds Stand On Nordstrom, Inc. (JWN)?
    insidermonkey.com

    Where Do Hedge Funds Stand On Nordstrom, Inc. (JWN)?

    After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms…

  • Olin Corporation (OLN): Are Hedge Funds Right About This Stock?
    insidermonkey.com

    Olin Corporation (OLN): Are Hedge Funds Right About This Stock?

    Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge…

  • Mal wieder pünktlich ! 4717 Aktien mit Levermann Auswertung
    langfristig-gedacht.de

    Mal wieder pünktlich ! 4717 Aktien mit Levermann Auswertung

    Mal wieder pünktlich ! 4717 Aktien mit Levermann Auswertung | Langfristig gedacht. Langfristig, smart, investieren.

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    This morning 150 companies reached new 52-week highs.
    Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm by market cap to set a new …

  • The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
    benzinga.com

    The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
    Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …

  • The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
    markets.businessinsider.com

    The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates

    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    This morning 470 companies set new 52-week highs.
    Facts of Interest: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a …

  • The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
    benzinga.com

    The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 7) …

Schreibe einen Kommentar

Community Kommentar Anonymer Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile

  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen Halozyme Therapeutics Inc am höchsten gewichtet ist Insgesamt in 11 ETFs enthalten

0,89% in iShares Healthcare Innovation  UCITS  ETF

0,58% in First Trust Mid Cap Growth  AlphaDEX®  ETF

0,47% in iShares Nasdaq US Biotechnology  UCITS  ETF

0,41% in iShares Ageing Population  UCITS  ETF

0,33% in Global X Longevity Thematic ETF

0,10% in iShares  MSCI USA  Small Cap  UCITS  ETF

Dir gefallen die Informationen zu Halozyme Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Halozyme Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Halozyme Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Halozyme Therapeutics Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Unternehmen aus den Branchen Gesundheitsdienstleistungen und Wissenschaft

Kategorien
Aktien
Apollo Endosurgery
Zum Portrait “Apollo Endosurgery”
Kategorien
Aktien
Acorda Therapeutics
Zum Portrait “Acorda Therapeutics”